A global provider of mission critical biopharma transport services
Envirotainer is the global market leader in mission critical temperature controlled supply chain solutions for the transportations of biopharmaceuticals
- Responsible AdvisorAli Farahani
Envirotainer was established in 1985 and is headquartered in Stockholm, Sweden. The company is a global market leader in air transport of temperature sensitive pharmaceuticals. With the world's largest fleet of specialized containers and close collaboration with airlines and freight forwarders, Envirotainer meets the pharmaceutical industry's complex need for fast and safe cold chain shipments where the pharmaceutical maintains exactly the right temperature throughout transport - from factory to end user.
Biological drugs are very temperature sensitive and large values are lost every year due to shortcomings in the logistics chain. Envirotainer's solutions provide the opportunity to meet complex and regulatory requirements when transporting these medicines under controlled temperatures. Thus, the company has a key role to play in ensuring that vital treatments, such as vaccines, insulin and oncological drugs, reach patients safely. Envirotainer delivered two million doses of medication every day in 2021.
Market trends and drivers
Envirotainer is uniquely positioned as the market leader and industry gold standard, in a highly attractive, resilient and strongly growing niche market with exposure to the underlying biopharma market. The market growth is supported by secular trends such as growing and aging global population, stricter pharma regulatory requirements and innovation of pharma products requiring cold chain solutions.
Millions of people across the globe depend on the safe delivery of biopharmaceuticals that require temperature control to maintain their integrity and quality. Today, lack of access to medicines is a cause for distress that disproportionately impacts underserved communities, whose situation is likely to be exacerbated by chronic diseases resulting from changing diets and lifestyles, as well as from air and water pollution. Envirotainer expands access to vital pharmaceuticals and vaccines through its patient-safe, reliable and efficient cold chain solutions, which also offer one of the lowest carbon footprint solutions in the industry.
EQT Private Equity will support Envirotainer in its next phase of growth by accelerating expansion in APAC and further driving growth in its other core markets, while investing behind new technology innovations, digitalization and sustainability in its operations.
Board of directors
- ChairpersonJarl Dahlfors
- Board memberAli Farahani
- Board memberSimon Tillmo
- Board memberCamilla Macapili Languille
- Board memberTom Thomasson
- Board memberWes Wheeler
- Board memberAndreas Jacobsson
- CEOPeter Gisel-Ekdahl
- CFOJonas Söderkvist